Vistakon introduces 1-Day Acuvue TruEye CLs

Article

Vistakon Division of Johnson & Johnson Vision Care Inc. has announced the U.S. introduction of 1-Day Acuvue TruEye (narafilcon A) contact lenses.

 

Jacksonville, FL-Vistakon Division of Johnson & Johnson Vision Care Inc. has announced the U.S. introduction of 1-Day Acuvue TruEye (narafilcon A) contact lenses (CLs). 1-Day Acuvue TruEye is now available at some U.S. eyecare professionals’ (ECP’s) offices, with distribution expected to grow in the coming months.

The lens features Hydraclear 1 Technology, which attracts tear film to help maintain the natural ocular environment for all-day comfort, High O2 Consumption, allowing 100 percent corneal oxygen consumption at all points across minus and plus powers, and Class-1 UV-blocking, offering patients the highest level of UV protection in a contact lens, blocking approximately 96 percent of UV-A rays and greater than 99 percent of UV-B rays that reach the lens.

1-Day Acuvue TruEye (narafilcon A) will gradually replace 1-Day Acuvue TruEye (narafilcon B), which was launched in the U.S. in 2010. 

Dave Brown, Vistakon president, said: “Our aim is to quickly transition to 1-Day Acuvue TruEye (narafilcon A), and we will provide doctors with a number of tools to help smooth the conversion process for ECPs and patients. We are confident that 1-Day Acuvue TruEye (narafilcon A) will help doctors make more patients happy, and drive additional patient referrals-the key to practice growth.”

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Allen, OD, FAAO, Dipl ABO, plans to talk all things ocular surface for optometrists and ophthalmologists alike.
Another drop in the presbyopia bucket: Dr Bloomenstein shares his excitement for the FDA approval of Vizz
1 expert in this video
© 2025 MJH Life Sciences

All rights reserved.